Shire has entered a new year with a new non-executive director, as it has appointed Ian Clark to the board. His new duties started immediately.
Clark served as Chief Executive Officer (CEO) and Director of Genentech Inc, which is part of the Roche Group, and Head of North American Commercial Operations for Roche until December 31, 2016.
Shire’s Chairman, Susan Kilsby,said that this was a timely appointment of a person with in-depth knowledgeof the biotechnology sector and breadth of operational experience
Kilsby said: “(His experience) stand to serve Shire well as we look forward to growing our business and addressing unmet patient needs world-wide.”
Clark added: “Shire has demonstrated commitment to being the global leader in rare diseases and to delivering value to its patients, physicians, shareholders and other stakeholders. I look forward to working with Susan and the rest of the Board in pursuing a successful future for the company.”